Complete cure of HBV-HDV co-infection after 24 weeks of combination therapy with pegylated interferon and ribavirin in a patient co-infected with HBV/HCV/HDV/HIV

Journal of Hepatology

Volumn 50, Issue 2, 2009, Pages 432-434

  Gozlan, Joel ^a,c   Lacombe, Karine ^a,d,e   Gault, Elyanne ^b   Raguin, Gilles ^a   Girard, Pierre Marie ^a,d,e  

^a HÔPITAL SAINT ANTOINE   (France)

^b AVICENNE HOSPITAL   (France)

^c CENTRE DE RECHERCHE DES CORDELIERS   (France)

^d INSERM   (France)

^e SORBONNE UNIVERSITÉ   (France)

Author keywords

AIDS; Co infection; Hepatitis B; Hepatitis C; Hepatitis delta; Pegylated interferon

Indexed keywords

EFAVIRENZ; HEPATITIS B ANTIGEN; INDINAVIR; LAMIVUDINE; PEGINTERFERON ALPHA2B; RIBAVIRIN; STAVUDINE;

ADULT; ARTICLE; CASE REPORT; DELTA AGENT HEPATITIS; DRUG WITHDRAWAL; HEPATITIS B; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LIVER BIOPSY; MALE; MIXED INFECTION; PRIORITY JOURNAL; TREATMENT DURATION; VIRUS REPLICATION;

EID: 58149279270     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2008.05.029     Document Type: Article

References (11)

1. Niro G.A., Rosina F., and Rizzetto M. Treatment of hepatitis D. J Viral Hepat 12 (2005) 2-9
2. Castelnau C., Le Gal F., Ripault M.P., Gordien E., Martinot-Peignoux M., Boyer N., et al. Efficacy of peginterferon alpha-2b in chronic hepatitis delta: relevance of quantitative RT-PCR for follow-up. Hepatology 44 (2006) 728-735
3. Niro G.A., Ciancio A., Gaeta G.B., Smedile A., Marrone A., Olivero A., et al. Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta. Hepatology 44 (2006) 713-720
4. Erhardt A., Gerlich W., Starke C., Wend U., Donner A., Sagir A., et al. Treatment of chronic hepatitis delta with pegylated interferon-alpha2b. Liver Int 26 (2006) 805-810
5. Le Gal F., Gordien E., Affolabi D., Hanslik T., Alloui C., Deny P., et al. Quantification of hepatitis delta virus RNA in serum by consensus real-time PCR indicates different patterns of virological response to interferon therapy in chronically infected patients. J Clin Microbiol 43 (2005) 2363-2369
6. Rosa I., Costes L., Garrait V., and Chousterman M. Efficacy of pegylated interferon alpha-2b for the treatment of chronic delta hepatitis in a patient co-infected with HIV. AIDS 19 (2005) 2177-2178
7. Wu J.C., Chen P.J., Kuo M.Y., Lee S.D., Chen D.S., and Ting L.P. Production of hepatitis delta virus and suppression of helper hepatitis B virus in a human hepatoma cell line. J Virol 65 (1991) 1099-1104
8. Schuttler C.G., Fiedler N., Schmidt K., Repp R., Gerlich W.H., and Schaefer S. Suppression of hepatitis B virus enhancer 1 and 2 by hepatitis C virus core protein. J Hepatol 37 (2002) 855-862
9. Gunsar F., Akarca U.S., Ersoz G., Kobak A.C., Karasu Z., Yuce G., et al. Two-year interferon therapy with or without ribavirin in chronic delta hepatitis. Antivir Ther 10 (2005) 721-726
10. Chen P.J., Kuo M.Y., Chen M.L., Tu S.J., Chiu M.N., Wu H.L., et al. Continuous expression and replication of the hepatitis delta virus genome in Hep G2 hepatoblastoma cells transfected with cloned viral DNA. Proc Natl Acad Sci USA 87 (1990) 5253-5257
11. Smedile A., Casey J.L., Cote P.J., Durazzo M., Lavezzo B., Purcell R.H., et al. Hepatitis D viremia following orthotopic liver transplantation involves a typical HDV virion with a hepatitis B surface antigen envelope. Hepatology 27 (1998) 1723-1729